For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction.

TitleThe BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction.
Publication TypeJournal Article
Year of Publication2005
AuthorsYang H, Li Q, Fan J, Holloman WK, Pavletich NP
JournalNature
Volume433
Issue7026
Pagination653-7
Date Published2005 Feb 10
ISSN1476-4687
KeywordsAdenosine Triphosphatases, Bacteriophage phi X 174, BRCA2 Protein, Crossing Over, Genetic, DNA, DNA Damage, DNA Repair, DNA, Single-Stranded, DNA, Viral, DNA-Binding Proteins, Fungal Proteins, Nucleic Acid Conformation, Protein Conformation, Rad51 Recombinase, Ustilago
Abstract

The BRCA2 tumour suppressor is essential for the error-free repair of double-strand breaks (DSBs) in DNA by homologous recombination. This is mediated by RAD51, which forms a nucleoprotein filament with the 3' overhanging single-stranded DNA (ssDNA) of the resected DSB, searches for a homologous donor sequence, and catalyses strand exchange with the donor DNA. The 3,418-amino-acid BRCA2 contains eight approximately 30-amino-acid BRC repeats that bind RAD51 (refs 5, 6) and a approximately 700-amino-acid DBD domain that binds ssDNA. The isolated BRC and DBD domains have the opposing effects of inhibiting and stimulating recombination, respectively, and the role of BRCA2 in repair has been unclear. Here we show that a full-length BRCA2 homologue (Brh2) stimulates Rad51-mediated recombination at substoichiometric concentrations relative to Rad51. Brh2 recruits Rad51 to DNA and facilitates the nucleation of the filament, which is then elongated by the pool of free Rad51. Brh2 acts preferentially at a junction between double-stranded DNA (dsDNA) and ssDNA, with strict specificity for the 3' overhang polarity of a resected DSB. These results establish a BRCA2 function in RAD51-mediated DSB repair and explain the loss of this repair capacity in BRCA2-associated cancers.

DOI10.1038/nature03234
Alternate JournalNature
PubMed ID15703751

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587